Anticorps PSMC4 (G-5): sc-166529
- L'Anticorps PSMC4 (G-5) est un monoclonal de souris IgG1 (chaîne légère kappa) fourni en 200 µg/ml
- soulevée à l'encontre des acides aminés 1-167 correspondant à N-terminus de PSMC4 d'origine human.
- recommandé pour la détection de PSMC4 d'origine mouse, rat et human par WB, IP, IF et ELISA; également réactif avec d'autres espèces, dont et canine and bovine
- m-IgG Fc BP-HRP et 1 BP-HRP">m-IgG1 BP-HRP sont les réactifs de détection secondaire préférés pour PSMC4 Antibody (G-5) for WB applications. Ces réactifs sont désormais proposés en lots avec PSMC4 Antibody (G-5)(voir les informations de commande ci-dessous).
ACCÈS RAPIDE AUX LIENS
In eukaryotic cells, selective breakdown of cellular proteins is ensured by their ubiquitination and subsequent degradation by the 26S proteasome. At specific stages of development, embryo- and tissue-specific components of the 26S proteasome are formed, which are responsible for proteolysis. These components of the 26S proteasome include Rpn10a through Rpn10e, or, alternatively, pUb-R2 through pUb-R5, and can be generated by a single Rpn10 gene by developmentally regulated alternative splicing. Gankyrin and p44S10 are proteasome regulatory particles that are expressed in heart, liver, skeletal muscle and pancreas. Proteasome component C2 (PROS-30), also designated Macropain subunit C2, is a prosomal protein involved in a non-lysosomal atp/ubiquitin-dependent proteolytic pathway. PSMC4 (26S protease regulatory subunit 6B) is involved in the ATP-dependent degradation of ubiquitinated proteins. PSMC4 interacts with with gankyrin, a liver oncoprotein as well as with a liver-specific member of the nuclear hormone receptor superfamily.
Informations pour la commande
| Nom du produit | Ref. Catalogue | COND. | Prix HT | QTÉ | Favoris | |
Anticorps PSMC4 (G-5) | sc-166529 | 200 µg/ml | $316.00 | |||
PSMC4 (G-5): m-IgG Fc BP-HRP Kit | sc-540117 | 200 µg Ab; 10 µg BP | $354.00 | |||
PSMC4 (G-5): m-IgG1 BP-HRP Kit | sc-541913 | 200 µg Ab; 20 µg BP | $354.00 |